Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Banana flower stamens extract is a botanical extract derived from the male reproductive parts (stamens) of the banana flower, typically from the *Musa* genus. Developed primarily as a nutraceutical or functional food ingredient by companies such as TCI Co., Ltd., it is investigated for its potential therapeutic benefits in managing benign prostatic hyperplasia (BPH). The extract is believed to exert its effects by inhibiting the enzyme 5-alpha reductase, which is responsible for converting testosterone into dihydrotestosterone (DHT), a potent androgen that drives prostate enlargement. By reducing DHT levels, the extract aims to prevent or alleviate urinary symptoms associated with BPH.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on banana flower stamens extract.